BioSpace News Archive

ViaCyte, Inc. , a clinical stage regenerative medicine company, today announced the appointment of Brittany Bradrick as Chief Financial Officer. Ms. Bradrick joins ViaCyte from Insulet Corporation where she was Vice President, Strategy and Corporate Development. Prior to that, she was Director, Business Development and Alliance Manageme

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, is establishing a general grant program to support the education of African-American patients about cutaneous T-cell lymphomas (CTCL) and address racial disparities in diagnosis, treatment and outcomes. Studie

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, announced the closing of its upsized underwritten public offering of 3,047,040 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase up to 397,440 additional shares of common stock, at a public

Breast Cancer patients are 60 percent more likely to die of cancer after surviving a heart attack, a new study finds.

BioMatrix Specialty Pharmacy announced today preferred network status for AscellaHealth’s bleeding disorder patient population. The decision to include BioMatrix in the PBM’s national network was based

In lieu of an in-person update to the media, Dr. Howard Njoo, Canada’s Deputy Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada’s Chief Public Health Officer.

InductiveHealth Informatics (InductiveHealth), a public health technology firm known for bringing innovation to the public health informatics industry and currently playing a critical role in the COVID-19 public health response, welcomes Alexis Sulyma to the team as chief growth officer to drive the firm’s continued expansion.

Major League Lacrosse (MLL) today announced a partnership with Biodesix, Inc., whereby Biodesix will be the exclusive provider of COVID-19 testing for the upcoming 2020 MLL season.

Professor Cheng Chao-Min of the Institute of Biomedical Engineering at National Tsing Hua University has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more efficient use of such critical equipment as respirators.

We were originally going to make this announcement in March, but as you all are well aware, we were forced to turn our attention to addressing the public health emergency posed by the COVID-19 pandemic.